Enhabit, Inc. logo EHAB - Enhabit, Inc.

Inactive Ticker EHAB is not actively trading. Quotes and analytics may be stale.
Price: -- -- | CONSENSUS: Hold DETAILS
STRONG
BUY
0
BUY 2
HOLD 8
SELL 1
STRONG
SELL
0
| PRICE TARGET: $13.53 DETAILS
HIGH: $14.00
LOW: $12.00
MEDIAN: $13.80
CONSENSUS: $13.53
DOWNSIDE: 1.96%
AlphaVal

AlphaVal

Deterministic, archetype-aware fair value

Distressed or Transitioning 70% confidence

Primary model: Current FCF × Depressed Multiple

Valuation Signal Overvalued Strong
Trading 410.0% above fair value
Current Price $13.80
Bear Case $0.00 100.0% downside ($0.00 - $13.80) / $13.80 = -100.0% FCF continues to decline, 4x multiple
Fair Value $2.71 80.4% downside ($2.71 - $13.80) / $13.80 = -80.4% Current FCF stabilizes, 6x multiple
Bull Case $1.37 90.1% downside ($1.37 - $13.80) / $13.80 = -90.1% Credible recovery, multiple re-rates to 8x

Adjust Assumptions

6.0x

Key Value Driver

Whether the core business model is intact or structurally impaired

Implied Market Multiple 17.7x

Plain-Language Summary

Our base-case estimate uses Current FCF × Depressed Multiple. We then blend that result with the average analyst price target of $13.53 from 11 analysts, using a 20% weight on analyst consensus. That produces an estimated intrinsic value of $2.71 per share.

Warnings

Don't assume past cash flow levels will return — the company's troubles may have permanently reduced its ability to generate profits.
A stock can look cheap on paper and still lose half its value if the underlying business is permanently damaged.
The wide range between our best and worst cases is intentional — pretending to know a precise value for a troubled company would be misleading.
Debt per share ($8.91) is more than half the stock price. With this much debt on a struggling business, the paths to recovery for shareholders are narrow.
Wall Street's average price target is $13.53 (from 11 analysts). Our estimate is 100% below the consensus -- consider that gap carefully.

Key Risks

  • Bullish DCF projections are fundamentally unknowable for distressed companies
  • M&A speculation can floor the stock above intrinsic value temporarily
  • Management credibility is a key input — new CEO expands the bull case